Technical Amendment: Freedom of Information Act Policies and Procedures, 60117 [2023-18866]

Download as PDF Federal Register / Vol. 88, No. 168 / Thursday, August 31, 2023 / Rules and Regulations immediate effect. USTR provided a 30day comment period, which ended on August 24, 2023. USTR did not receive any comments and is adopting the provisions of the interim final rule as a final rule with no changes. OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE 15 CFR Part 2004 RIN 0350–AA13 Technical Amendment: Freedom of Information Act Policies and Procedures List of Subjects in 15 CFR Part 2004 Administrative practice and procedure, Courts, Disclosure, Exemptions, Freedom of information, Government employees, Privacy, Records, Subpoenas, Testimony. Office of the United States Trade Representative (USTR). ACTION: Adoption of interim rule as final. AGENCY: This final rule adopts, without change, an interim final rule with a request for comments published in the Federal Register on July 25, 2023, that made a minor technical change to the USTR Freedom of Information Act (FOIA) regulation. DATES: Effective October 2, 2023. FOR FURTHER INFORMATION CONTACT: Janice Kaye or Monique Ricker at FOIA@ustr.eop.gov or 202–395–3150. SUPPLEMENTARY INFORMATION: SUMMARY: I. Technical Change On July 25, 2023, USTR published an interim final rule that made a technical change to § 2004.6 of the USTR FOIA regulation to align it with the statute and Office of Information Policy guidance about the compelling circumstances under which an agency must grant expedited processing. See 88 FR 47772. Although the interim final rule was effective upon publication, USTR provided a 30-day comment period, which ended on August 24, 2023. USTR did not receive any comments and is adopting the interim final rule without any changes. ddrumheller on DSK120RN23PROD with RULES1 II. Regulatory Flexibility Act USTR considered the impact of this rule and determined that it will not have a significant economic impact on a substantial number of small business entities because it applies only to USTR’s internal operations and legal obligations. 5 U.S.C. 605(b). III. Paperwork Reduction Act The final rule does not contain any information collection requirement that requires the approval of the Office of Management and Budget under the Paperwork Reduction Act (44 U.S.C. 3501 et seq.). IV. Administrative Procedure Act (APA) On July 25, 2023, USTR published an interim final rule (88 FR 47772) and determined that there was a basis under the Administrative Procedure Act for issuing the interim final rule with VerDate Sep<11>2014 16:30 Aug 30, 2023 Jkt 259001 PART 2004—DISCLOSURE OF RECORDS AND INFORMATION Accordingly, the interim final rule published in the Federal Register on July 25, 2023, at 88 FR 47772, amending 15 CFR part 2004, is adopted as a final rule without change. ■ Janice Kaye, Chief FOIA Officer, Office of the United States Trade Representative. [FR Doc. 2023–18866 Filed 8–30–23; 8:45 am] BILLING CODE 3290–F3–P DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Parts 1303 and 1315 [Docket No. DEA–455] RIN 1117–AB49 Management of Quotas for Controlled Substances and List I Chemicals Drug Enforcement Administration, Department of Justice. ACTION: Final rule. AGENCY: The Drug Enforcement Administration (DEA) is publishing this final rule to manage the quotas for controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, held by DEA-registered manufacturers. This final rule will define the types of quotas, update the method to abandon quota, clarify the current language to ensure that both manufacturers and distributors are required to obtain certification of a buyer’s quota, reduce overall inventories, formalize the existing practice of use-specific subcategories for individual manufacturing and procurement quotas, and modify existing deadlines to fix/issue quotas. This final rule will also amend certain regulations to implement updates to the Controlled Substances Act made by the Substance Use-Disorder Prevention that Promotes Opioid Recovery Treatment for Patients and Communities Act. SUMMARY: PO 00000 Frm 00013 Fmt 4700 Sfmt 4700 60117 This final rule is effective November 29, 2023. DATES: FOR FURTHER INFORMATION CONTACT: Scott A. Brinks, Regulatory Drafting & Policy Support Section (DPW), Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362–3261. SUPPLEMENTARY INFORMATION: Legal Authority The Controlled Substances Act (CSA) authorizes the Administrator of the Drug Enforcement Administration (DEA) (by delegation from the Attorney General) to promulgate rules and regulations that he deems necessary and appropriate for the efficient execution of his functions under subchapter I (Control and Enforcement) and subchapter II (Import and Export). 21 U.S.C. 871(b) and 958(f). Subchapter I includes provisions which require the Administrator to establish the aggregate production quota for each basic class of controlled substance listed in schedules I and II and the assessment of annual needs for the ephedrine, pseudoephedrine, and phenylpropanolamine to be manufactured in the United States each calendar year to provide for the estimated medical, scientific, research, and industrial needs of the United States, lawful export requirements, and the establishment and maintenance of reserve stocks. 21 U.S.C. 826. The Administrator shall take the following quota actions for a basic class of controlled substance listed in schedules I and II and ephedrine, pseudoephedrine, and phenylpropanolamine pursuant to stipulated conditions: limit or reduce individual production quotas for each registered manufacturer,1 and fix individual manufacturing quotas for registrants.2 On October 24, 2018, Congress revised the CSA through the Substance Use-Disorder Prevention that Promotes Opioid Recovery Treatment for Patients and Communities (SUPPORT) Act. These revisions will be noted and included in these proposed regulations, where applicable. Through this Act, the Administrator, by way of delegation from the Attorney General, may now set quota in terms of the pharmaceutical dosage-form. 1 21 2 21 E:\FR\FM\31AUR1.SGM U.S.C. 826(b). U.S.C. 826(d). 31AUR1

Agencies

[Federal Register Volume 88, Number 168 (Thursday, August 31, 2023)]
[Rules and Regulations]
[Page 60117]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18866]



[[Page 60117]]

=======================================================================
-----------------------------------------------------------------------

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

15 CFR Part 2004

RIN 0350-AA13


Technical Amendment: Freedom of Information Act Policies and 
Procedures

AGENCY: Office of the United States Trade Representative (USTR).

ACTION: Adoption of interim rule as final.

-----------------------------------------------------------------------

SUMMARY: This final rule adopts, without change, an interim final rule 
with a request for comments published in the Federal Register on July 
25, 2023, that made a minor technical change to the USTR Freedom of 
Information Act (FOIA) regulation.

DATES: Effective October 2, 2023.

FOR FURTHER INFORMATION CONTACT: Janice Kaye or Monique Ricker at 
[email protected] or 202-395-3150.

SUPPLEMENTARY INFORMATION:

I. Technical Change

    On July 25, 2023, USTR published an interim final rule that made a 
technical change to Sec.  2004.6 of the USTR FOIA regulation to align 
it with the statute and Office of Information Policy guidance about the 
compelling circumstances under which an agency must grant expedited 
processing. See 88 FR 47772. Although the interim final rule was 
effective upon publication, USTR provided a 30-day comment period, 
which ended on August 24, 2023. USTR did not receive any comments and 
is adopting the interim final rule without any changes.

II. Regulatory Flexibility Act

    USTR considered the impact of this rule and determined that it will 
not have a significant economic impact on a substantial number of small 
business entities because it applies only to USTR's internal operations 
and legal obligations. 5 U.S.C. 605(b).

III. Paperwork Reduction Act

    The final rule does not contain any information collection 
requirement that requires the approval of the Office of Management and 
Budget under the Paperwork Reduction Act (44 U.S.C. 3501 et seq.).

IV. Administrative Procedure Act (APA)

    On July 25, 2023, USTR published an interim final rule (88 FR 
47772) and determined that there was a basis under the Administrative 
Procedure Act for issuing the interim final rule with immediate effect. 
USTR provided a 30-day comment period, which ended on August 24, 2023. 
USTR did not receive any comments and is adopting the provisions of the 
interim final rule as a final rule with no changes.

List of Subjects in 15 CFR Part 2004

    Administrative practice and procedure, Courts, Disclosure, 
Exemptions, Freedom of information, Government employees, Privacy, 
Records, Subpoenas, Testimony.

PART 2004--DISCLOSURE OF RECORDS AND INFORMATION

0
Accordingly, the interim final rule published in the Federal Register 
on July 25, 2023, at 88 FR 47772, amending 15 CFR part 2004, is adopted 
as a final rule without change.

Janice Kaye,
Chief FOIA Officer, Office of the United States Trade Representative.
[FR Doc. 2023-18866 Filed 8-30-23; 8:45 am]
BILLING CODE 3290-F3-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.